De Angelis, C., Nagi, C., Hoyt, C. C., Liu, L., Roman, K., Wang, C., . . . Schiff, R. (2019). Evaluation of the predictive role of tumor immune infiltrate in HER2-positive breast cancer patients treated with neoadjuvant anti-HER2 therapy without chemotherapy. Clin Cancer Res.
Citação norma ChicagoDe Angelis, Carmine, et al. "Evaluation of the Predictive Role of Tumor Immune Infiltrate in HER2-positive Breast Cancer Patients Treated With Neoadjuvant Anti-HER2 Therapy Without Chemotherapy." Clin Cancer Res 2019.
Citação norma MLADe Angelis, Carmine, et al. "Evaluation of the Predictive Role of Tumor Immune Infiltrate in HER2-positive Breast Cancer Patients Treated With Neoadjuvant Anti-HER2 Therapy Without Chemotherapy." Clin Cancer Res 2019.